Ukachi N Emeruwa, Hooman Azad, Samsiya Ona, Shai Bejerano, Sarah Alnafisee, Jordan Emont, Sharon Mathew, Michelle Batlle, Denice Arnold, Erinma P Ukoha, Louise C Laurent, Marni Jacobs, Janice J Aubey, Russell S Miller, Cynthia Gyamfi-Bannerman
BACKGROUND: Birthing people with de novo postpartum hypertensive disorders remain among the highest risk for severe maternal morbidity. Randomized controlled trials demonstrate a benefit to oral loop-diuretics in decreasing postpartum hypertensive morbidity in patients with an antenatal diagnosis of preeclampsia. It is not known whether this same therapy benefits patients at risk for new-onset postpartum hypertension OBJECTIVE: To evaluate whether oral furosemide can reduce risk for de novo postpartum hypertension (dnPPHTN) among high-risk birthing people by reducing post-delivery blood pressure...
April 17, 2024: American Journal of Obstetrics and Gynecology